44 related articles for article (PubMed ID: 6760247)
21. Duration of the dormant state in an established cell line of human hematopoietic cells.
Clarkson BD; Fried J; Chou TC; Strife A; Ferguson R; Sullivan S; Kitahara T; Oyama A
Cancer Res; 1977 Dec; 37(12):4506-22. PubMed ID: 336195
[No Abstract] [Full Text] [Related]
22. Interruption of tumor cell cycle progression through proteasome inhibition: implications for cancer therapy.
Dou QP; Smith DM; Daniel KG; Kazi A
Prog Cell Cycle Res; 2003; 5():441-6. PubMed ID: 14593738
[TBL] [Abstract][Full Text] [Related]
23. Combination chemotherapy--theory and practice.
Capizzi RL; Keiser LW; Sartorelli AC
Semin Oncol; 1977 Jun; 4(2):227-53. PubMed ID: 327555
[No Abstract] [Full Text] [Related]
24. Scientific basis and criticism of current therapy of acute leukemia.
Stryckmans P; Delforge A; Bron D; Malarme M; Debusscher L; Suciu S; Ronge-Collard E
Blood Cells; 1982; 8(3):603-22. PubMed ID: 6760936
[TBL] [Abstract][Full Text] [Related]
25. Chemosensitivity testing using microplate adenosine triphosphate-based luminescence measurements.
Kurbacher CM; Cree IA
Methods Mol Med; 2005; 110():101-20. PubMed ID: 15901931
[TBL] [Abstract][Full Text] [Related]
26. Camptothecins: from bench research to hospital wards.
Potmesil M
Cancer Res; 1994 Mar; 54(6):1431-9. PubMed ID: 8137244
[No Abstract] [Full Text] [Related]
27. Activity of epothilones.
Kolman A
Curr Opin Investig Drugs; 2005 Jun; 6(6):616-22. PubMed ID: 15988913
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant breast cancer therapy: current status and future strategies--growth kinetics and the improved drug therapy of breast cancer.
Norton L
Semin Oncol; 1999 Feb; 26(1 Suppl 3):1-4. PubMed ID: 10203263
[TBL] [Abstract][Full Text] [Related]
29. [Basic aspects of cancer chemotherapy (author's transl)].
Arai T; Kuroda S
Rinsho Byori; 1974 Aug; 22(Suppl):145-58. PubMed ID: 4610220
[No Abstract] [Full Text] [Related]
30. Limited role of cell kinetics in clinical cancer chemotherapy.
Hall TC
Natl Cancer Inst Monogr; 1971 Dec; 34():15-7. PubMed ID: 4946579
[No Abstract] [Full Text] [Related]
31. Evaluation of tumor size response metrics to predict survival in oncology clinical trials.
Bruno R; Mercier F; Claret L
Clin Pharmacol Ther; 2014 Apr; 95(4):386-93. PubMed ID: 24419563
[TBL] [Abstract][Full Text] [Related]
32. [Chemotherapy of experimental leukoses and some tumoral viroses].
Winter D; Nastac E
Stud Cercet Inframicrobiol; 1966; 17(4):323-52. PubMed ID: 5340859
[No Abstract] [Full Text] [Related]
33. Role of laboratory chemosensitivity testing in the selection of cancer chemotherapy for individual patients.
Selby PJ; Raghavan D
J Clin Pathol; 1981 May; 34(5):455-63. PubMed ID: 7019254
[TBL] [Abstract][Full Text] [Related]
34. [Interactions of antineoplastic drugs].
Robak T
Postepy Hig Med Dosw; 1981; 35(3):243-58. PubMed ID: 6752915
[No Abstract] [Full Text] [Related]
35. Clinical aspects of drug resistance.
Holland JF
Antibiot Chemother (1971); 1978; 23():238-46. PubMed ID: 348082
[No Abstract] [Full Text] [Related]
36. Spheroids for studies of drug effects.
Nederman T; Twentyman P
Recent Results Cancer Res; 1984; 95():84-102. PubMed ID: 6396762
[No Abstract] [Full Text] [Related]
37. Criteria for analyzing interactions between biologically active agents.
Berenbaum MC
Adv Cancer Res; 1981; 35():269-335. PubMed ID: 7041539
[No Abstract] [Full Text] [Related]
38. Multiple-drug resistance in human cancer.
Pastan I; Gottesman M
N Engl J Med; 1987 May; 316(22):1388-93. PubMed ID: 3553950
[No Abstract] [Full Text] [Related]
39. In vitro methods to predict for patient response to chemotherapy.
Von Hoff DD; Weisenthal L
Adv Pharmacol Chemother; 1980; 17():133-56. PubMed ID: 7004139
[No Abstract] [Full Text] [Related]
40. Human tumor cloning: drug sensitivity testing clinical correlations.
Alberts DS; Salmon SE; Moon TE
Prog Clin Cancer; 1982; 8():147-79. PubMed ID: 6760247
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
